Evaluation of efficacy and safety of OROS® methylphenidate HCl (MPH) extended-release tablets, methylphenidate tid, and placebo in children with ADHD

被引：0
|
作者：
Wolraich, ML [1 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
来源：
PEDIATRIC RESEARCH | 2000年 / 47卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
207
引用
收藏
页码：36A / 36A
页数：1
相关论文
共 50 条
  • [31] Treatment with extended-release methylphenidate (OROS®-MPH) in children with ADHD is associated with improvement in social functioning throughout the active day -: results from an open-label, non-interventional trial
    Stollhoff, K.
    Schauble, B.
    Czekalla, J.
    Klose, N.
    Gerwe, M.
    [J]. PHARMACOPSYCHIATRY, 2007, 40 (05) : 238 - 238
  • [32] Exploring the Impact of Once-Daily OROS® Methylphenidate (MPH) on Symptoms and Quality of Life in Children and Adolescents with ADHD Transitioning From Immediate-Release MPH
    Kordon, Andreas
    Stollhoff, Kirsten
    Niederkirchner, Kaete
    Mattejat, Fritz
    Rettig, Klaus
    Schaeuble, Barbara
    [J]. POSTGRADUATE MEDICINE, 2011, 123 (05) : 27 - 38
  • [33] Multiscale assessment of treatment efficacy in adults with ADHD: A randomized placebo-controlled, multi-centre study with extended-release methylphenidate
    Retz, Wolfgang
    Roesler, Michael
    Ose, Claudia
    Scherag, Andre
    Alm, Barbara
    Philipsen, Alexandra
    Fischer, Roland
    Ammer, Richard
    [J]. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2012, 13 (01): : 48 - 59
  • [34] Comparison of the pharmacokinetics and clinical efficacy of new extended-release formulations of methylphenidate
    Maldonado, Rafael
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (08) : 1001 - 1014
  • [35] Comparative efficacy of once-a-day extended-release methylphenidate, two-times-daily immediate-release methylphenidate, and placebo in a laboratory school setting
    Döpfner, M
    Gerber, WD
    Banaschewski, T
    Breuer, D
    Freisleder, FJ
    Gerber-von Müller, G
    Günter, M
    Hässler, F
    Ose, C
    Rothenberger, A
    Schmeck, K
    Sinzig, J
    Stadler, C
    Uebel, H
    Lehmkuhl, G
    [J]. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2004, 13 (Suppl 1) : 93 - 101
  • [36] Comparative acute efficacy and tolerability of OROS and immediate release formulations of methylphenidate in the treatment of adults with ADHD
    Biederman, J.
    Spencer, T. J.
    Mick, E.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S545 - S546
  • [37] ELECTRONICALLY MONITORED ADHERENCE RATES WITH EVENING-DOSED DELAYED-RELEASE AND EXTENDED-RELEASE METHYLPHENIDATE IN CHILDREN WITH ADHD
    Childress, Ann Catherine
    Pliszka, Steven R.
    Cutler, Andrew J.
    Marraffino, Andrea
    DeSousa, Norberto J.
    Sallee, Floyd R.
    Incledon, Bev
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2020, 59 (10): : S152 - S153
  • [38] Efficacy and safety of OROS® methylpheniclate in adults with ADHD:: the long-acting methylphenidate in adult ADHD (LAMDA) trial
    Roesler, M.
    Trott, G. E.
    Philipsen, A.
    Gerwe, M.
    Lee, E.
    Medori, R.
    Schauble, B.
    [J]. PHARMACOPSYCHIATRY, 2007, 40 (05) : 248 - 248
  • [39] Relative Bioavailability of Methylphenidate Extended-release Chewable Tablets Chewed Versus Swallowed Whole
    Abbas, Richat
    Childress, Ann C.
    Nagraj, Praneeta
    Rolke, Richard
    Berry, Sally A.
    Palumbo, Donna R.
    [J]. CLINICAL THERAPEUTICS, 2018, 40 (05) : 733 - 740
  • [40] Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD
    Greenhill, Laurence
    Kollins, Scott
    Abikoff, Howard
    McCracken, James
    Riddle, Mark
    Swanson, James
    McGough, James
    Wigal, Sharon
    Wigal, Tim
    Vitiello, Benedetto
    Skrobala, Anne
    Posner, Kelly
    Ghuman, Jaswinder
    Cunningham, Charles
    Davies, Mark
    Chuang, Shirley
    Cooper, Tom
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2006, 45 (11): : 1284 - 1293
12345